Abstract: A machine control permits the selection of input values defining configurations of motors on the machine in desired master-slave relationships. Individual master-slave dependencies may be selectively activated and deactivated. In response to a new commanded velocity for a master motor the control is effective to alter the velocities of all motors dependent therefrom as a function of change of velocity of the master motor and selectable slave ratios.

Abstract: A movable platen structure for an injection molding machine in which the platen is in the form of a box-like structure that includes spaced front and rear plates. The platen structure includes a plurality of longitudinally extending beam members that interconnect the front and rear plates and are positioned in parallel relationship and in a generally rectangular array. The rear plate includes on its rear face a plurality of vertically extending pillow block members for pivotally carrying a pivot pin, the pillow block members having inclined sides that intersect with the rear face of the rear plate. Extending across the front face of the rear plate and opposite from the ends of the respective pillow blocks are an upper and a lower transverse beam member, each of which is formed integrally with the rear plate to provide additional structural stiffening and thereby permit the rear plate to be of a thinner and lighter structure.

Abstract: A method of inhibiting or reducing the irritation of skin resulting from allergic contact dermatitis, caused by contact with natural or synthetic allergenic agents, e.g. poison ivy, and dinitrochlorobenzene, respectively, is described. The method comprises applying to the skin an irritating reducing effective amount of a protective agent which is an organic compound having at least two polar groups, e.g. carboxyl groups, separated by a chain of at least 15 atoms the majority of which are carbon atoms and optionally containing a cyclic moiety of at least 5 atoms, prior to contact of the skin with the allergenic agent. The protective agent may be combined in a pharmacologically acceptable base for application to the skin.